Prime Medicine Launches Proposed Equity Offering

Company Prime Medicine Event Type Proposed public offering ($125 million) Modality Prime editing Asset Prime-editing pipeline Target Not applicable Disease Area Genetic disease (liver, lung, immunology/oncology programs) Summary Prime Medicine announced a proposed $125 million underwritten common-stock offering on November 10. The launch is a…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *